These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 3158690

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D, Chatterjee K, Parmley WW, Atherton B, Curran D, Kereiakes A, Spangenberg R.
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
    Amin DK, Shah PK, Hulse S, Shellock FG, Swan HJ.
    Am Heart J; 1984 Nov; 108(5):1285-92. PubMed ID: 6238513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM, Bristow MR, Mason JW.
    Am J Cardiol; 1987 Aug 14; 60(5):57C-62C. PubMed ID: 2956870
    [Abstract] [Full Text] [Related]

  • 13. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M, Levine TB, Cohn JN.
    Circulation; 1986 Mar 14; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF, Valdes AM, Reddy PS.
    Circulation; 1986 Mar 14; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
    Kereiakes DJ, Viquerat C, Lanzer P, Botvinick EH, Spangenberg R, Buckingham M, Parmley WW, Chatterjee K.
    Am Heart J; 1984 Nov 14; 108(5):1278-84. PubMed ID: 6238512
    [Abstract] [Full Text] [Related]

  • 20. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG, De Marco T, Kwasman M, Lau D, Liu M, Chatterjee K.
    J Am Coll Cardiol; 1992 Dec 14; 20(7):1542-8. PubMed ID: 1452928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.